Weight Gain With Insulin Therapy In Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2010, Vol 17, Issue 4
Abstract
Type 2 diabetes mellitus is a disease with progressive beta-cell decline and most patients will require insulin therapy to control their glycemic homeostasis. The aims of this study is to estimate the weight gain associated with insulin therapy in type 2 diabetes patients failing oral antidiabetic drugs. We retrospectively evaluated 58 patients, 36 women (62.06%) and 22 men (37.93%), with type 2 diabetes who required insulin for poor metabolic control, despite dietary measures and maximal-dose oral agents. The subjects were between 47 and 71 years. 25 patients required analog insulin and 33 patients biosynthetic human insulin. The insulin regimes were conventional treatment (basal insulin, premixed insulin-11 patients in treatment with analog insulin, and 15 patients with biosynthetic human insulin) or intensive-treatment (basal/bolus insulin-14 patients in treatment with analog insulin and 18 patients with biosynthetic human insulin). The following parameters were determined at the beginning of the study, and were monitored over 5 years of insulinotherapy: weight, glycosylated hemoglobin (HbA1c), insulin requirement and types of insulin. Mean age at the diagnosis of diabetes was 50.16 ± 5.39 years (range 38-62 years) and mean age at insulin introduction was 55.80 ± 6-16 years (range 42-71 years). Mean weight at insulin introduction was 71.00 ± 9.50 kg (range 58-101 kg), after 1 year 73.92 ± 9.47 kg (range 63-105 kg) and after 5 years 76.71 ±. 9.71kg (range 67-107 kg). The mean baseline levels of HbA1c was 9.61 ± 0.80% and after 5 years of insulin therapy 8.02 ± 0.44%. The mean weight gain in the study group after 1 year from started insulin was 2.86 ± 0.86 kg and after 5 years 6.08 ±1.59 kg. The weight gain was directly correlated with the insulin dose. Weight gain was significantly greater in the intensive-treatment group compared with the conventional-treatment group.
Authors and Affiliations
Rucsandra Dănciulescu Miulescu, Suzana Dănoiu, Denisa Margină, Cătălina Poiană, Liviu Serb, Constantin Ionescu-Tîrgoviste
Keywords
Related Articles
- EP ID EP85317
- DOI -
- Views 100
- Downloads 0
A SENSITIVE METHOD FOR DETECTING DINUCLEOTIDE ISLANDS AND CLUSTERS THROUGH DEPTH ANALYSIS
The field of bioinformatics is an essential asset for modern biology. In recent years, after the appearance of GWS (Genome Wide Scan) studies, powerful bioinformatics methods have been developed. In order to understand t...
The Impact Of An Educational Program In The Management Of Patients With Chronic Hepatitis C
Introduction: This study was designed to measure the impact of lifestyle changes, involving a diet therapy and physical exercises in patients with chronic hepatitis C (CHC). Methods: The study was conducted during Januar...
ONCE AGAIN ABOUT HEALTHY NUTRITION AND ITS ROLE IN PREVENTION OF TYPE 2 DIABETES
VALIDITY AND REPRODUCTIBILITY OF A FOOD FREQUENCY QUESTIONNAIRE DESIGNED TO CHARACTERIZE THE DIET OF WOMEN OF CHILDBEARING AGE
Objectives: To test the validity and reproducibility of a food frequency questionnaire (FFQ) administered by interview, consisting of 127 items, developed to characterize the food intake of women of fertile age, in compa...
CARDIOVASCULAR RISK CALCULATED ON A GROUP OF PATIENTS WITH TYPE 1 DM DIAGNOSED AT LEAST 10 YEARS AGO
Diabetic nephropathy is the most common worldwide cause of renal chronic disease in terminal stage requiring a renal substitution therapy. Microalbuminuria is an independent risk factor for developing diabetic renal dise...